+390677209020 | +39 0267380552 info@direnzo.biz | sedemilano@direnzo.biz | Italian Language

UDI tracking of medical devices and in vitro diagnostics: new rules in January 2024

UDI Tracking

On 8 January and 15 January 2024 the obligations on the traceability of some types of in vitro diagnostics and medical devices will become effective.

Health professionals must meet such obligations in order to comply with the norms provided for by the European Directive adopted in 2023 by the Ministry of Health decrees.

These two decrees, published in the Official Journal last May, establish the provisions regarding the registration and storage of the Unique Device Identifier (UDI) by health institutions and health professionals, including pharmacies.

Which medical devices are involved in the traceability obligation?

The obligation to register and store UDI codes affects CE-marked devices according to Regulation EU 2017/745  and CE-marked devices according to Regulation EU 2017/746. In particular, the following classes are involved:

  • class III implantable devices;
  • class III devices other than implantable devices;
  • class IIb implantable devices;
  • class D in vitro diagnostics.

Manufacturers shall attribute a UDI code to a device and to all involved packaging, based on the device class, within the dates provided for by the above mentioned Regulations.

More specifically, the code is to be reported on the label and on all packaging materials of the concerned device, excluding transport containers.

In this way, traceability is ensured as early as the manufacturing up to the device availability on the market, making it easily identifiable in order report serious incidents and take any safety corrective action required.

The registered information shall be stored for a minimum period of 10 years as of the date of the device registration.

The non compliance with this obligation can be fined up to 24,500 euros.

It is therefore essential that concerned health professionals begin to store UDI code as provided for by the regulation, although the implementational side regarding controls by authorities is still under definition.

To this end, Federfarma has prepared a customised repository for each pharmacy, informing concerned health professionals with an official communication.

Currently, most devices are still complying with previous Directives, so in this case the UDI obligations do not apply, but the system is moving to an update involving a growing number of products: it is already possible to register UDI codes into EUDAMED.

By including the traceability system in the context of a public database fully working in the European market, an improvement in the device post-market surveillance can be expected.

This will make incident reporting more rapid and effective, followed by targeted corrective actions, supported in turn by a better inter-cooperation by health professionals as well as competent authorities.